Skip to content Skip to footer
Close
Dr. Patrik Säterö

M.D.

Dr. Patrik Säterö

Patrik Säterö lives and work in Gothenburg, Sweden as a PMNR, and is a qualified physical therapist.

Sweden

Biography

Patrik Säterö lives and work in Gothenburg, Sweden as a PMNR, and is also a qualified physical therapist. Botulinum toxin has been the main tool for Patrik since 2005 in treating spasticity, chronic migraine and hyperhidrosis. He has his own private clinic since 2014, Rehdo. He enjoys training colleagues in the Nordic countries and has written a practice handbook about using botulinum toxin in spasticity treatment. He has been an active participant in clinical studies such as BEST and SPACE and different post authorization studies of botulinum toxin.

Other previous team members

team-morelada

Dr Susana Moraleda

team-x-bavikatte

Dr. Ganesh Bavikatte

team-x-ketchum

Dr. Nicholas Ketchum

© 2024 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.